Literature DB >> 26476139

Bench to bedside: NK cells and control of metastasis.

Yelena Krasnova1, Eva Maria Putz2, Mark J Smyth1, Fernando Souza-Fonseca-Guimaraes3.   

Abstract

Natural killer (NK) cells play a critical role in host immune responses against tumor growth and metastasis. The numerous mechanisms used by NK cells to regulate and control cancer metastasis include interactions with tumor cells via specific receptors and ligands as well as direct cytotoxicity and cytokine-induced effector mechanisms. NK cells also play a role in tumor immunosurveillance and inhibition of metastases formation by recognition and killing of tumor cells. In this review, we provide an overview of the molecular mechanisms of NK cell responses against tumor metastases and discuss multiple strategies by which tumors evade NK cell-mediated surveillance. With an increasing understanding of the molecular mechanisms driving NK cell activity, there is a growing potential for the development of new cancer immunotherapies. Here we provide a historical background on NK cell-based therapies and discuss the implications of recent and ongoing clinical trials using novel NK cell-based immunotherapy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antitumor control; Clinical trials and emerging therapies; Immunosurveillance; Integration of cellular signaling pathways; Metastasis; NK cells

Mesh:

Substances:

Year:  2015        PMID: 26476139     DOI: 10.1016/j.clim.2015.10.001

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  30 in total

1.  Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases.

Authors:  Dipti Vijayan; Deborah S Barkauskas; Kimberley Stannard; Erin Sult; Rebecca Buonpane; Kazuyoshi Takeda; Michele W L Teng; Kris Sachsenmeier; Carl Hay; Mark J Smyth
Journal:  Oncoimmunology       Date:  2017-04-05       Impact factor: 8.110

Review 2.  Challenges of NK cell-based immunotherapy in the new era.

Authors:  Fang Fang; Weihua Xiao; Zhigang Tian
Journal:  Front Med       Date:  2018-07-25       Impact factor: 4.592

3.  Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.

Authors:  Yulong Gao; Fernando Souza-Fonseca-Guimaraes; Tobias Bald; Susanna S Ng; Arabella Young; Shin Foong Ngiow; Jai Rautela; Jasmin Straube; Nic Waddell; Stephen J Blake; Juming Yan; Laurent Bartholin; Jason S Lee; Eric Vivier; Kazuyoshi Takeda; Meriem Messaoudene; Laurence Zitvogel; Michele W L Teng; Gabrielle T Belz; Christian R Engwerda; Nicholas D Huntington; Kyohei Nakamura; Michael Hölzel; Mark J Smyth
Journal:  Nat Immunol       Date:  2017-07-31       Impact factor: 25.606

Review 4.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

Review 5.  Roles of cytotoxic and helper innate lymphoid cells in cancer.

Authors:  Camille Guillerey
Journal:  Mamm Genome       Date:  2018-09-03       Impact factor: 2.957

Review 6.  Cancer Immunoprevention: Current Status and Future Directions.

Authors:  Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-02-27       Impact factor: 4.291

7.  Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity.

Authors:  Fernando Souza-Fonseca-Guimaraes; Stephen J Blake; Amani Makkouk; Cariad Chester; Holbrook E Kohrt; Mark J Smyth
Journal:  Oncoimmunology       Date:  2016-06-30       Impact factor: 8.110

Review 8.  The Regulation of Pathways of Inflammation and Resolution in Immune Cells and Cancer Stem Cells by Selenium.

Authors:  Bastihalli T Diwakar; Arvind M Korwar; Robert F Paulson; K Sandeep Prabhu
Journal:  Adv Cancer Res       Date:  2017-08-31       Impact factor: 6.242

9.  Gemcitabine Activates Natural Killer Cells to Attenuate Pancreatic Cancer Recurrence.

Authors:  David W Dawson; Martin E Fernandez-Zapico
Journal:  Gastroenterology       Date:  2016-06-29       Impact factor: 22.682

10.  PET Imaging of the Natural Killer Cell Activation Receptor NKp30.

Authors:  Travis M Shaffer; Amin Aalipour; Christian M Schürch; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2020-06-12       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.